Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.
about
Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivoManipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.Progress and Trends in Complement TherapeuticsComplement in immune and inflammatory disorders: therapeutic interventions.The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair.Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.The innate immune response in reperfused myocardium.Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal.Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy.Complement depletion protects lupus-prone mice from ischemia-reperfusion-initiated organ injury.IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
P2860
Q33644184-42A0E211-A3B0-4DAC-A152-36D9EEDEDCB8Q36463266-A3B55F25-1B42-4931-AD1C-EDB6D88D160AQ36479278-A5CD02D1-D222-433F-9B18-C95B7636EADBQ36756854-0FE9D62E-83D3-4C57-9E5B-11F5A2827C66Q37139158-4D5297EF-F638-422E-B280-E429E1D562EDQ37680021-8C03A5D6-88E4-4B44-AD31-18C3D360B946Q37977824-0A158A04-E1EF-4527-AB8D-877BC85B1850Q38227381-248D51FC-74EE-4817-ACAB-C3F0130BF529Q41379852-B358F649-56F0-4506-B7A1-D5A55070ADF9Q47580544-56A56694-0F51-4E91-B8F1-8BC03DD5AFB3Q47734765-BEDE2421-FC93-4CE9-AB9F-D608FFCB5592Q53554275-5AB8E85C-0D7B-4CD7-998C-2DDB861A67E7Q54285801-BA7C3157-4B2F-47D6-A7E0-79660825645CQ58746571-4DD00EA4-781D-484E-B4DD-F3F073FC3315
P2860
Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@ast
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@en
type
label
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@ast
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@en
prefLabel
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@ast
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@en
P2093
P2860
P356
P1476
Treatment with the C5a recepto ...... ne ischemia-reperfusion model.
@en
P2093
Bengt Larsson
David Erlinge
Göran K Olivecrona
Jesper van der Pals
Joey F A Ubachs
Matthias Götberg
Mikael Kanski
Patrik Andersson
Sasha Koul
P2860
P2888
P356
10.1186/1471-2261-10-45
P577
2010-09-27T00:00:00Z
P5875
P6179
1038367004